Jane Street’s Anterix ATEX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$691K Buy
18,100
+8,000
+79% +$253K ﹤0.01% 7295
2025
Q4
$220K Buy
+10,100
New +$210K ﹤0.01% 9520
2025
Q2
Sell
-14,800
Closed -$542K 9580
2025
Q1
$542K Buy
+14,800
New +$509K ﹤0.01% 6713
2023
Q1
Sell
-85,000
Closed -$2.73M 8983
2022
Q4
$2.73M Buy
+85,000
New +$2.89M ﹤0.01% 3367
2021
Q3
Sell
-7,400
Closed -$444K 9886
2021
Q2
$444K Sell
7,400
-41,000
-85% -$2.05M ﹤0.01% 7459
2021
Q1
$2.28M Buy
+48,400
New +$1.99M ﹤0.01% 3756

Other funds holding ATEX

Jane Street's ATEX Position: Q1 2026 in Review

Jane Street increased its Anterix (ATEX) stake by 165% in Q1 2026, buying an estimated $8.29M and bringing the position to 420,857 shares worth $16.1M. The position accounts for ﹤0.01% of the portfolio, ranked #1984.

Jane Street first reported a position in ATEX in Q2 2020 and has held it in 19 quarters since. 132 funds tracked by Wall St. Rank hold ATEX as of Q1 2026.

  • Jane Street held 420,857 shares of Anterix worth $16.1M as of Q1 2026.
  • Jane Street bought 261,843 Anterix shares in Q1 2026, an estimated $8.29M.
  • Anterix made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #1984 holding.
  • Jane Street first reported a position in Anterix in Q2 2020 and has held it in 19 quarters since.
  • 132 funds tracked by Wall St. Rank held Anterix as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.